Ketorolac Tromethamine Injection, Solution
Product Images NDC 76420-184

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 76420-184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Ketorolac Tromethamine 01)

Image Description (Ketorolac Tromethamine 01)
Chemical structure of ketorolac tromethamine, showing the molecular arrangement for C15H13NO3 and C4H11NO3 components combined in the compound.*
FDA Label Image

Image Description (Ketorolac Tromethamine 02)

Image Description (Ketorolac Tromethamine 02)
Label for Ketorolac Tromethamine Injection, USP 60 mg/2 mL distributed by Hospira, Inc., relabeled by Enovachem Pharmaceuticals. The label shows NDC 76420-184-02 with a quantity of 2 vials, containing 2 mL of a clear, slightly yellow solution. It includes lot and batch numbers as placeholders, storage instructions (20-25°C), and dispensing caution information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.